Active specific immunotherapy against adenocarcinomas.
MacLean
G D
GD
Cross Cancer Institute, Faculty of Medicine, University of Alberta, Edmonton Canada.
Reddish
M A
MA
Bowen-Yacyshyn
M B
MB
Poppema
S
S
Longenecker
B M
BM
D000230:Adenocarcinoma / Q000276:immunology / Q000628:therapy*; D000818:Animals; D000951:Antigens, Neoplasm / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000628:therapy; D004195:Disease Models, Animal; D000939:Epitopes; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D016233:Immunotherapy, Active; D051379:Mice; D010051:Ovarian Neoplasms / Q000628:therapy; D014407:Tumor Cells, Cultured
D000951:Antigens, Neoplasm; D000939:Epitopes